RNAi screening comes of age: Improved techniques and complementary approaches

Nature Reviews Molecular Cell Biology

Volumn 15, Issue 9, 2014, Pages 591-600

  Mohr, Stephanie E ^a   Smith, Jennifer A ^a   Shamu, Caroline E ^a   Neumüller, Ralph A ^a   Perrimon, Norbert ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; UNTRANSLATED RNA;

BIOINFORMATICS; CELL CULTURE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; FOLLOW UP; GENE FUNCTION; GENE SILENCING; GENETIC SCREENING; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE;

ANIMALS; GENE REGULATORY NETWORKS; GENETIC TESTING; HUMANS; INVERTED REPEAT SEQUENCES; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84906702408     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm3860     Document Type: Review

References (104)

1. Rana, T. M. Illuminating the silence: Understanding the structure and function of small RNAs. Nature Rev. Mol. Cell Biol. 8, 23-36 (2007).
2. Boutros, M. & Ahringer, J. The art and design of genetic screens: RNA interference. Nature Rev. Genetics 9, 554-566 (2008).
3. Grimm, S. The art and design of genetic screens: Mammalian culture cells. Nature reviews. Genetics 5, 179-189 (2004).
4. Zhuang, J. J. & Hunter, C. P. RNA interference in Caenorhabditis elegans: Uptake, mechanism, and regulation. Parasitology 139, 560-573 (2012).
5. Bernards, R., Brummelkamp, T. R. & Beijersbergen, R. L. shRNA libraries and their use in cancer genetics. Nature Methods 3, 701-706 (2006).
6. Surendranath, V., Theis, M., Habermann, B. H. & Buchholz, F. Designing efficient and specific endoribonuclease-prepared siRNAs. Methods Mol. Biol. 942, 193-204 (2013).
7. Mohr, S., Bakal, C. & Perrimon, N. Genomic screening with RNAi: Results and challenges. Annu. Rev. Biochem. 79, 37-64 (2010).
8. Panda, D. & Cherry, S. Cell-based genomic screening: Elucidating virus-host interactions. Curr. Opin. Virol. 2, 784-792 (2012).
9. Cherry, S. What have RNAi screens taught us about viral-host interactions? Curr. Opin. Microbiol. 12, 446-452 (2009).
10. Cherry, S. Genomic RNAi screening in Drosophila S2 cells: What have we learned about host-pathogen interactions? Curr. Opin. Microbiol. 11, 262-270 (2008).
11. Whitehead, K. A., Langer, R. & Anderson, D. G. Knocking down barriers: Advances in siRNA delivery. Nature Rev. Drug Discov. 8, 129-138 (2009).
12. Perrimon, N., Ni, J. Q. & Perkins, L. In vivo RNAi: Today and tomorrow. Cold Spring Harb. Perspect. Biol. 2, a003640 (2010).
13. Hu, Y. et al. UP TORR: Online tool for accurate and Up to Date annotation of RNAi Reagents. Genetics 195, 37-45 (2013).
14. Sin, O., Michels, H. & Nollen, E. A. Genetic screens in Caenorhabditis elegans models for neurodegenerative diseases. Biochim. Biophys. Acta http: //dx.doi. org/10.1016/j.bbadis.2014.01.015 (2014).
15. Birmingham, A. et al. 3 UTR seed matches, but not overall identity, are associated with RNAi off-Targets. Nature Methods 3, 199-204 (2006).
16. Birmingham, A. et al. Statistical methods for analysis of high-Throughput RNA interference screens. Nature Methods 6, 569-575 (2009).
17. Root, D. E., Hacohen, N., Hahn, W. C., Lander, E. S. & Sabatini, D. M. Genome-scale loss of function screening with a lentiviral RNAi library. Nature Methods 3, 715-719 (2006).
18. Mohr, S. E. & Perrimon, N. RNAi screening: New approaches, understandings, and organisms. Wiley Interdiscip. Rev. RNA 3, 145-158 (2012).
19. Yanos, M. E., Bennett, C. F. & Kaeberlein, M. Genome-wide RNAi longevity screens in Caenorhabditis elegans. Curr. Genom. 13, 508-518 (2012).
20. Sigoillot, F. D. & King, R. W. Vigilance and validation: Keys to success in RNAi screening. ACS Chem. Biol. 6, 47-60 (2011).
21. Wagner, D. E., Ho, J. J. & Reddien, P. W. Genetic regulators of a pluripotent adult stem cell system in planarians identified by RNAi and clonal analysis. Cell Stem Cell 10, 299-311 (2012).
22. Forsthoefel, D. J. et al. An RNAi screen reveals intestinal regulators of branching morphogenesis, differentiation, and stem cell proliferation in planarians. Dev. Cell 23, 691-704 (2012).
23. Rink, J. C., Vu, H. T. & Sanchez Alvarado, A. The maintenance and regeneration of the planarian excretory system are regulated by EGFR signaling. Development 138, 3769-3780 (2011).
24. Mony, B. M. et al. Genome-wide dissection of the quorum sensing signalling pathway in Trypanosoma brucei. Nature 505, 681-685 (2014).
25. Echeverri, C. J. et al. Minimizing the risk of reporting false positives in large-scale RNAi screens. Nature Methods 3, 777-779 (2006).
26. Schmidt, E. E. et al. GenomeRNAi: A database for cell-based and in vivo RNAi phenotypes, 2013 update. Nucleic Acids Res. 41, D1021-D1026 (2013).
27. Sigoillot, F. D. et al. A bioinformatics method identifies prominent off-Targeted transcripts in RNAi screens. Nature Methods 9, 363-366 (2012).
28. Buehler, E. et al. siRNA off-Target effects in genome-wide screens identify signaling pathway members. Scientif. Rep. 2, 428 (2012).
29. Bhinder, B. & Djaballah, H. Systematic analysis of RNAi reports identifies dismal commonality at gene-level & reveals an unprecedented enrichment in pooled shRNA screens. Comb.Chem. High Throughput Screen 16, 665-681 (2013).
30. Bushman, F. D. et al. Host cell factors in HIV replication: Meta-Analysis of genome-wide studies. PLoS Pathog. 5, e1000437 (2009).
31. Kaelin, W. G. Jr. Molecular biology. Use and abuse of RNAi to study mammalian gene function. Science 337, 421-422 (2012).
32. He, L. & Hannon, G. J. MicroRNAs: Small RNAs with a big role in gene regulation. Nature Rev. Genetics 5, 522-531 (2004).
33. Bartel, D. P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
34. Franceschini, A. et al. Specific inhibition of diverse pathogens in human cells by synthetic microRNA-like oligonucleotides inferred from RNAi screens. Proc. Natl Acad. Sci. USA http: Dx.doi.org/10.1073/ pnas.1402353111 (2014).
35. Behlke, M. A. Chemical modification of siRNAs for in vivo use. Oligonucleotides 18, 305-319 (2008).
36. Yilmazel, B. et al. Online GESS: Prediction of miRNA-like off-Target effects in large-scale RNAi screen data by seed region analysis. BMC Bioinformat. 15, 192 (2014).
37. Buehler, E., Chen, Y. C. & Martin, S. C911: A bench-level control for sequence specific siRNA off-Target effects. PloS ONE 7, e51942 (2012).
38. Bassik, M. C. et al. Rapid creation and quantitative monitoring of high coverage shRNA libraries. Nature Methods 6, 443-445 (2009).
39. Hoffman, G. R. et al. Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1 deficient cancers. Proc. Natl Acad. Sci. USA 111, 3128-3133 (2014).
40. Fellmann, C. et al. Functional identification of optimized RNAi triggers using a massively parallel sensor assay. Mol. Cell 41, 733-746 (2011).
41. Kittler, R. et al. RNA interference rescue by bacterial artificial chromosome transgenesis in mammalian tissue culture cells. Proc. Natl Acad. Sci. USA 102, 2396-2401 (2005).
42. Kondo, S., Booker, M. & Perrimon, N. Cross-species RNAi rescue platform in Drosophila melanogaster. Genetics 183, 1165-1173 (2009).
43. Langer, C. C., Ejsmont, R. K., Schonbauer, C., Schnorrer, F. & Tomancak, P. In vivo RNAi rescue in Drosophila melanogaster with genomic transgenes from Drosophila pseudoobscura. PloS ONE 5, e8928 (2010).
44. Kranz, D. & Boutros, M. A synthetic lethal screen identifies FAT1 as an antagonist of caspase 8 in extrinsic apoptosis. EMBO J. 33, 181-197 (2014).
45. Gaj, T., Gersbach, C. A. & Barbas, C. F. 3rd. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. 31, 397-405 (2013).
46. Wu, X. et al. Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nature Biotech. 32, 670-676 (2014).
47. Heintze, J., Luft, C. & Ketteler, R. A CRISPR CASe for high-Throughput silencing. Frontiers Genet. 4, 193 (2013).
48. Sessions, O. M. et al. Discovery of insect and human dengue virus host factors. Nature 458, 1047-1050 (2009).
49. Rohn, J. L. et al. Comparative RNAi screening identifies a conserved core metazoan actinome by phenotype. J. Cell Biol. 194, 789-805 (2011
50. Imberg-Kazdan, K. et al. A genome-wide RNA interference screen identifies new regulators of androgen receptor function in prostate cancer cells. Genome Res. 23, 581-591 (2013).
51. Neumuller, R. A. et al. Conserved regulators of nucleolar size revealed by global phenotypic analyses. Sci. Signal. 6, ra70 (2013).
52. Dixon, S. J., Andrews, B. J. & Boone, C. Exploring the conservation of synthetic lethal genetic interaction networks. Commun. Integr. Biol. 2, 78-81 (2009).
53. Frost, A. et al. Functional repurposing revealed by comparing S. pombe and S. cerevisiae genetic interactions. Cell 149, 1339-1352 (2012).
54. Joyce, E. F., Williams, B. R., Xie, T. & Wu, C. T. Identification of genes that promote or antagonize somatic homolog pairing using a high-Throughput FISH-based screen. PLoS Genet. 8, e1002667 (2012).
55. Yin, Z. et al. A screen for morphological complexity identifies regulators of switch-like transitions between discrete cell shapes. Nature Cell Biol. 15, 860-871 (2013).
56. Collinet, C. et al. Systems survey of endocytosis by multiparametric image analysis. Nature 464, 243-249 (2010).
57. Laufer, C., Fischer, B., Billmann, M., Huber, W. & Boutros, M. Mapping genetic interactions in human cancer cells with RNAi and multiparametric phenotyping. Nature Methods 10, 427-431 (2013).
58. Sundaramurthy, V. et al. Integration of chemical and RNAi multiparametric profiles identifies triggers of intracellular mycobacterial killing. Cell Host Microbe 13, 129-142 (2013).
59. Snijder, B. et al. Single-cell analysis of population context advances RNAi screening at multiple levels. Mol. Systems Biol. 8, 579 (2012).
60. Avery, L. & Wasserman, S. Ordering gene function: The interpretation of epistasis in regulatory hierarchies. Trends Genet. 8, 312-316 (1992).
61. Baryshnikova, A. et al. Synthetic genetic array (SGA) analysis in Saccharomyces cerevisiae and Schizosaccharomyces pombe. Methods Enzymol. 470, 145-179 (2010).
62. Horn, T. et al. Mapping of signaling networks through synthetic genetic interaction analysis by RNAi. Nature Methods 8, 341-346 (2011).
63. Luo, J. et al. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 137, 835-848 (2009).
64. Steckel, M. et al. Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies. Cell Res. 22, 1227-1245 (2012).
65. Cheung, H. W. et al. Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer. Proc. Natl Acad. Sci. USA 108, 12372-12377 (2011).
66. Koh, J. L. et al. COLT-Cancer: Functional genetic screening resource for essential genes in human cancer cell lines. Nucleic Acids Res. 40, D957-D963 (2012).
67. Marcotte, R. et al. Essential gene profiles in breast, pancreatic, and ovarian cancer cells. Cancer Discov. 2, 172-189 (2012).
68. Zuber, J. et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 478, 524-528 (2011).
69. Beronja, S. et al. RNAi screens in mice identify physiological regulators of oncogenic growth. Nature 501, 185-190 (2013).
70. Zender, L. et al. An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell 135, 852-864 (2008).
71. Miller, P. G. et al. In Vivo RNAi screening identifies a leukemia-specific dependence on integrin β 3 signaling. Cancer Cell 24, 45-58 (2013).
72. Wuestefeld, T. et al. A Direct in vivo RNAi screen identifies MKK4 as a key regulator of liver regeneration. Cell 153, 389-401 (2013).
73. Zuber, J. et al. An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance. Genes Dev. 25, 1628-1640 (2011).
74. Livshits, G. & Lowe, S. W. Accelerating cancer modeling with RNAi and nongermline genetically engineered mouse models. Cold Spring Harbor Protoc. http: //dx.doi.org/10.1101/pdb.top069856 (2013).
75. Bartscherer, K., Pelte, N., Ingelfinger, D. & Boutros, M. Secretion of Wnt ligands requires Evi, a conserved transmembrane protein. Cell 125, 523-533 (2006).
76. Neely, G. G. et al. A genome-wide Drosophila screen for heat nociception identifies a2d3 as an evolutionarily conserved pain gene. Cell 143, 628-638 (2010).
77. Neumuller, R. A. et al. Stringent analysis of gene function and protein-protein interactions using fluorescently tagged genes. Genetics 190, 931-940 (2012).
78. Pastor-Pareja, J. C. & Xu, T. Shaping cells and organs in Drosophila by opposing roles of fat body-secreted Collagen IV and perlecan. Dev. Cell 21, 245-256 (2011).
79. Venken, K. J. et al. MiMIC: A highly versatile transposon insertion resource for engineering Drosophila melanogaster genes. Nature Methods 8, 737-743 (2011).
80. Firnhaber, C. & Hammarlund, M. Neuron-specific feeding RNAi in C. elegans and its use in a screen for essential genes required for GABA neuron function. PLoS Genet. 9, e1003921 (2013).
81. Qadota, H. et al. Establishment of a tissue-specific RNAi system in C. elegans. Gene 400, 166-173 (2007).
82. Port, F., Chen, H. M., Lee, T. & Bullock, S. L. Optimized CRISPR/Cas tools for efficient germline and somatic genome engineering in Drosophila. Proc. Natl Acad. Sci. USA http: //dx.doi.org/10.1073/pnas.1405500111 (2014).
83. Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protoc. 4, 44-57 (2009).
84. Vinayagam, A. et al. Protein complex-based analysis framework for high-Throughput data sets. Sci. Signal. 6, rs5 (2013).
85. Kwon, Y. et al. The Hippo signaling pathway interactome. Science 342, 737-740 (2013).
86. Shamu, C. E., Wiemann, S. & Boutros, M. On target: A public repository for large-scale RNAi experiments. Nature Cell Biol. 14, 115 (2012).
87. Carette, J. E. et al. Haploid genetic screens in human cells identify host factors used by pathogens. Science 326, 1231-1235 (2009).
88. Carette, J E. et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477, 340-343 (2011).
89. Burckstummer, T. et al. A reversible gene trap collection empowers haploid genetics in human cells. Nature Methods 10, 965-971 (2013).
90. Wang, H. et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153, 910-918 (2013).
91. Wang, T., Wei, J. J., Sabatini, D. M. & Lander, E. S. Genetic screens in human cells using the CRISPR Cas9 system. Science 343, 80-84 (2014).
92. Shalem, O. et al. Genome-scale CRISPR Cas9 knockout screening in human cells. Science 343, 84-87 (2014).
93. Koike-Yusa, H., Li, Y., Tan, E. P., Velasco-Herrera Mdel, C. & Yusa, K. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nature Biotech. 32, 267-273 (2014).
94. Terns, R. M. & Terns, M. P. CRISPR-based technologies: Prokaryotic defense weapons repurposed. Trends Genet 30, 111-118 (2014).
95. Santhakumar, D. et al. Combined agonist-Antagonist genome-wide functional screening identifies broadly active antiviral microRNAs. Proc. Natl Acad. Sci. USA 107, 13830-13835 (2010).
96. Keklikoglou, I. et al. MicroRNA 520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF ?B and TGF-β signaling pathways. Oncogene 31, 4150-4163 (2012).
97. Leivonen, S. K. et al. High-Throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth. Mol. Oncol. 8, 93-104 (2014).
98. Du, L. et al. A high-Throughput screen identifies miRNA inhibitors regulating lung cancer cell survival and response to paclitaxel. RNA Biol. 10, 1700-1713 (2013).
99. Neijenhuis, S., Bajrami, I., Miller, R., Lord, C. J. & Ashworth, A. Identification of miRNA modulators to PARP inhibitor response. DNA Repair 12, 394-402 (2013).
100. Otto, E. A. et al. Candidate exome capture identifies mutation of SDCCAG8 as the cause of a retinal-renal ciliopathy. Nature Genet. 42, 840-850 (2010).
101. Mirkin, E. V. & Mirkin, S. M. To switch or not to switch: At the origin of repeat expansion disease. Mol. Cell 53, 1-3 (2014).
102. Kung, J. T., Colognori, D. & Lee, J. T. Long noncoding RNAs: Past, present, and future. Genetics 193, 651-669 (2013).
103. Thoma, C. R. et al. A high-Throughput-compatible 3D microtissue co culture system for phenotypic RNAi screening applications. J. Biomolecular Screen. 18, 1330-1337 (2013).
104. Marhefka, J. N. & Abbud-Antaki, R. A. Validation of the Cancer BioChip System as a 3D siRNA screening tool for breast cancer targets. PloS ONE 7, e46086 (2012